U.S. Markets open in 8 hrs 54 mins

Valeant Pharmaceuticals International, Inc. (VRX)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
14.15+0.25 (+1.80%)
At close: 4:00PM EDT
People also watch
Full screen
Previous Close13.90
Bid0.00 x 0
Ask0.00 x 0
Day's Range13.97 - 14.54
52 Week Range8.31 - 32.74
Avg. Volume19,097,893
Market Cap4.92B
PE Ratio (TTM)-3.50
EPS (TTM)-4.05
Earnings DateN/A
Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2010-11-10
1y Target EstN/A
Trade prices are not sourced from all markets
  • TheStreet.com5 hours ago

    Valeant Pharmaceuticals: Cramer's Top Takeaways

    Joe Papa, chairman and CEO of Valeant Pharmaceuticals International, talks to Jim Cramer about his company's turnaround.

  • MarketWatch8 hours ago

    Valeant Pharma works to resolve FDA concerns at Tampa plant

    Valeant Pharmaceuticals International Inc. shares ticked higher in the extended session Wednesday after the drugmaker said that issues from a Food and Drug Administration inspection were being resolved. ...

  • PR Newswire8 hours ago

    Valeant Receives FDA Confirmation Of Voluntary Action Indicated (VAI) Inspection Classification For Tampa Facility

    LAVAL, Quebec, Aug. 16, 2017 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant" or the "Company") today announced the U.S. Food and Drug Administration (FDA) confirmed it intends to issue a Voluntary Action Indicated (VAI) inspection classification for its Bausch + Lomb manufacturing facility in Tampa, Fla. as part of a forthcoming Establishment Inspection Record for the facility. With this confirmation, manufacturing uncertainties related to current and upcoming regulatory submissions will be eliminated for products manufactured at the Tampa facility.